Skip to main content

TEVA 7768 Pill - white oval, 14mm

Pill with imprint TEVA 7768 is White, Oval and has been identified as Everolimus 7.5 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Everolimus is used in the treatment of Neuroendocrine Carcinoma; Breast Cancer; Organ Transplant, Rejection Prophylaxis; Pancreatic Cancer; Renal Angiomyolipoma and belongs to the drug classes mTOR inhibitors, selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Everolimus 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 7768

Everolimus 7.5 mg TEVA 7768
Everolimus 7.5 mg TEVA 7768

Everolimus

Imprint
TEVA 7768
Strength
7.5 mg
Color
White
Size
14.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
MTOR inhibitors, Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Manufacturer
Pliva Hrvatska d.o.o.
National Drug Code (NDC)
00093-7768

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.